MENU

Eureka projects

The aim of this project is to develop a novel low-cost vaccine against pneumococcal disease that is suitable to be implemented in the emerging markets, using a new vaccine technology that allows intranasal delivery, low-cost vaccine production and broader protection.
Project ID: 
7200

Develop an oral formulation for monoclonal antibodies
Cut-off: 
8
Ranking: 
21
Project ID: 
11879

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.